Notable
TLN-499 in Combination With Venetoclax · Relapsed/Refractory Solid Tumors
Recruitment opened
Treeline Biosciences, Inc.Phase 1 NCT07713732 Registry history of NCT07713732 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Recruitment opened
Treeline Biosciences, Inc.Phase 1 NCT07713732 Registry history of NCT07713732 on ClinicalTrials.gov (opens the registry)
| Phase 1 | 4 |
Non-Hodgkin Lymphoma (2) · Lung Cancer (1) · Mesothelioma (1) · Sarcoma (1) · Small Cell Lung Cancer (1)